Cargando…
Silencing Aurora A leads to re-sensitization of breast cancer cells to Taxol through downregulation of SRC-mediated ERK and mTOR pathways
While Taxol has been reported to improve the clinical survival of breast cancer patients, subsequently developed drug-resistance of the cancer cells limits its final efficacy and applications. Previous studies suggested that Aurora A is involved in the development of the Taxol-resistance of breast c...
Autores principales: | Li, Yan, Zhou, Wanqi, Tang, Ke, Chen, Xiaoguang, Feng, Zhiqiang, Chen, Jindong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652950/ https://www.ncbi.nlm.nih.gov/pubmed/28849180 http://dx.doi.org/10.3892/or.2017.5908 |
Ejemplares similares
-
Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality
por: Zhang, Wenfeng, et al.
Publicado: (2019) -
mTOR Inhibition Leads to Src-Mediated EGFR Internalisation and Degradation in Glioma Cells
por: Colella, Barbara, et al.
Publicado: (2020) -
Synergy of Taxol and rhein lysinate associated with the downregulation of ERK activation in lung carcinoma cells
por: ZHEN, YONG-ZHAN, et al.
Publicado: (2013) -
Essential Roles of mTOR/Akt Pathway in Aurora-A Cell Transformation
por: Taga, Makoto, et al.
Publicado: (2009) -
Novel multi-kinase inhibitor, T03 inhibits Taxol-resistant breast cancer
por: Li, Yan, et al.
Publicado: (2018)